2012-10-06 19:11:51 - New Pharmaceuticals market report from Global Markets Direct: "Cerenis Therapeutics SA - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Cerenis Therapeutics SA - Product Pipeline Review - 2012" provides data on the Cerenis Therapeutics SA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Cerenis Therapeutics SA's corporate website, SEC filings, investor presentations and featured press releases, both from Cerenis Therapeutics SA and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468516_cerenis_therapeutics_sa_product_pipel ..


Scope

* Cerenis Therapeutics SA - Brief Cerenis Therapeutics SA overview including business description, key

information and facts, and its locations and subsidiaries.
* Review of current pipeline of Cerenis Therapeutics SA human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Cerenis Therapeutics SA with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Cerenis Therapeutics SA's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Cerenis Therapeutics SA's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Cerenis Therapeutics SA in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Cerenis Therapeutics SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Cerenis Therapeutics SA.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Cerenis Therapeutics SA and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Cerenis Therapeutics SA Snapshot
Cerenis Therapeutics SA Overview
Key Information
Key Facts
Cerenis Therapeutics SA - Research and Development Overview
Key Therapeutic Areas
Cerenis Therapeutics SA - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Cerenis Therapeutics SA - Pipeline Products Glance
Cerenis Therapeutics SA Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Cerenis Therapeutics SA - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Cerenis Therapeutics SA - Drug Profiles
CER-001
Product Description
Mechanism of Action
R&D Progress
CER-002
Product Description
Mechanism of Action
R&D Progress
CER-522
Product Description
Mechanism of Action
R&D Progress
CER-627
Product Description
Mechanism of Action
R&D Progress
CER-628
Product Description
Mechanism of Action
R&D Progress
HDL Receptor Enhancer
Product Description
Mechanism of Action
R&D Progress
Cerenis Therapeutics SA - Pipeline Products by Route of Administration
Cerenis Therapeutics SA - Pipeline Products By Mechanism of Action
Cerenis Therapeutics SA - Recent Pipeline Updates
Cerenis Therapeutics SA - Dormant Projects
Cerenis Therapeutics SA - Locations And Subsidiaries
Head Office
Financial Deals Landscape
Cerenis Therapeutics SA, Deals Summary
Cerenis Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Cerenis Therapeutics Secures $14 Million In Second Tranche Of Series C Financing
Cerenis Therapeutics Raises $3.7 Million In Venture Financing
Cerenis Therapeutics Secures $53.5 Million In Series B Financing
Licensing Agreements
Cerenis Therapeutics Enters Into Licensing Agreement With Montreal Heart Institute Research Centre
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Cerenis Therapeutics SA, Key Information
Cerenis Therapeutics SA, Key Facts
Cerenis Therapeutics SA - Pipeline by Indication, 2012
Cerenis Therapeutics SA - Pipeline by Stage of Development, 2012
Cerenis Therapeutics SA - Monotherapy Products in Pipeline, 2012
Cerenis Therapeutics SA - Phase II, 2012
Cerenis Therapeutics SA - Phase I, 2012
Cerenis Therapeutics SA - Pre-Clinical, 2012
Cerenis Therapeutics SA - Pipeline By Route of Administration, 2012
Cerenis Therapeutics SA - Pipeline Products By Mechanism of Action, 2012
Cerenis Therapeutics SA - Recent Pipeline Updates, 2012
Cerenis Therapeutics SA - Dormant Developmental Projects,2012
Cerenis Therapeutics SA, Deals Summary
Cerenis Therapeutics Secures $14 Million In Second Tranche Of Series C Financing
Cerenis Therapeutics Raises $3.7 Million In Venture Financing
Cerenis Therapeutics Secures $53.5 Million In Series B Financing
Cerenis Therapeutics Enters Into Licensing Agreement With Montreal Heart Institute Research Centre

List of Figures

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468516&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.